T. Rowe Price Associates
SPRY icon

T. Rowe Price Associates’s ARS Pharmaceuticals SPRY Stock Holding History

T. Rowe Price Associates’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
40,779
+6,991
+21% +$67K ﹤0.01% 2643
2025
Q4 		$394K Hold
33,788
– – ﹤0.01% 2501
2025
Q3 		$340K Buy
33,788
+6,397
+23% +$91.8K ﹤0.01% 2544
2025
Q2 		$478K Buy
27,391
+5,632
+26% +$81.3K ﹤0.01% 2325
2025
Q1 		$274K Buy
21,759
+1,841
+9% +$22.1K ﹤0.01% 2514
2024
Q4 		$211K Sell
19,918
-442,601
-96% -$6.2M ﹤0.01% 2654
2024
Q3 		$6.71M Buy
462,519
+446,799
+2,842% +$5.31M ﹤0.01% 1223
2024
Q2 		$134K Buy
+15,720
New +$140K ﹤0.01% 2697
2023
Q3 		– Sell
-16,537
Closed -$111K – 2912
2023
Q2 		$111K Buy
16,537
+4,936
+43% +$32.9K ﹤0.01% 2682
2023
Q1 		$76K Buy
+11,601
New +$89.1K ﹤0.01% 2733
2022
Q4 		– Sell
-26,500
Closed -$140K – 2976
2022
Q3 		$140K Sell
26,500
-139,700
-84% -$688K ﹤0.01% 2649
2022
Q2 		$705K Sell
166,200
-134,374
-45% -$469K ﹤0.01% 2063
2022
Q1 		$1.05M Buy
300,574
+900
+0.3% +$3.92K ﹤0.01% 1983
2021
Q4 		$2M Buy
+299,674
New +$2.44M ﹤0.01% 1712

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return